Erratum to: 5-Aminolevulinic acid combined with sodium ferrous citrate ameliorates H2O2-induced cardiomyocyte hypertrophy via activation of the MAPK/Nrf2/HO-1 pathway (Am J Physiol Cell Physiol, (2015) 308, C665-C672 (10.1152/ajpcell.00369.2014));5-Aminolevulinic acid combined with sodium ferrous citrate ameliorates H2O2-induced cardiomyocyte hypertrophy via activation of the MAPK/NRF2/HO-1 pathway

American Journal of Physiology - Cell Physiology

Volumn 308, Issue 8, 2015, Pages C665-C672

  Zhao, Mingyi ^a   Guo, Huiming ^a   Chen, Jimei ^a   Wang, Jinju ^b   Huang, Huanlei ^a   Zheng, Shaoyi ^a   Hei, Mingyan ^c   Li, Jiaxin ^a   Huang, Shuai ^a   Li, Jiani ^a   Ma, Xiaotang ^d   Chen, Yanfang ^b   Zhao, Lingling ^c   Zhuang, Jian ^a   Zhu, Ping ^a  

^a GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^b WRIGHT STATE UNIVERSITY   (United States)

^c CENTRAL SOUTH UNIVERSITY   (China)

^d GUANGDONG MEDICAL UNIVERSITY   (China)

Author keywords

5 aminolevulinic acid; Cardiomyocyte hypertrophy; Heme oxygenase 1; Mitogen activated protein kinase; Nuclear factor erythroid 2 related factor 2

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; AMINOLEVULINIC ACID; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; ATRIAL NATRIURETIC FACTOR; CARDIOVASCULAR AGENT; DICHLORODIHYDROFLUORESCEIN DIACETATE; HEME OXYGENASE 1; HYDROGEN PEROXIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; MYOSIN HEAVY CHAIN BETA; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; SODIUM FERROUS CITRATE; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; ANTIOXIDANT; BRAIN NATRIURETIC PEPTIDE; FERROUS ION; HMOX1 PROTEIN, MOUSE; MEMBRANE PROTEIN; MONOFERROUS ACID CITRATE; MYOSIN HEAVY CHAIN; NFE2L2 PROTEIN, MOUSE; VENTRICULAR MYOSIN;

ARTICLE; CELL SURFACE; CONTROLLED STUDY; ENZYME ACTIVATION; GENE EXPRESSION; HEART CELL CULTURE; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; HL 1 CELL; MORPHOMETRICS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CARDIOMEGALY; CELL LINE; GENETICS; HEART MUSCLE CELL; METABOLISM; MOUSE; PATHOLOGY; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

AMINOLEVULINIC ACID; ANIMALS; ANTIOXIDANTS; ATRIAL NATRIURETIC FACTOR; CARDIOMEGALY; CELL LINE; FERROUS COMPOUNDS; HEME OXYGENASE-1; HYDROGEN PEROXIDE; MEMBRANE PROTEINS; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; MYOCYTES, CARDIAC; MYOSIN HEAVY CHAINS; NATRIURETIC PEPTIDE, BRAIN; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; VENTRICULAR MYOSINS;

EID: 84928040757     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.zh0-7799-corr.2015     Document Type: Erratum

References (37)

1. Afanas’ev I. ROS and RNS signaling in heart disorders: could antioxidant treatment be successful? Oxid Med Cell Longev 2011: 293769, 2011.
2. Brunt KR, Tsuji MR, Lai JH, Kinobe RT, Durante W, Claycomb WC, Ward CA, Melo LG. Heme oxygenase-1 inhibits pro-oxidant induced hypertrophy in HL-1 cardiomyocytes. Exp Biol Med (Maywood) 234: 582–594, 2009.
3. Daryadel A, Bogdanova A, Gassmann M, Mueller X, Zund G, Seifert B, Lehalle C, Frossard N, Tavakoli R. Multikinase inhibitor sorafenib prevents pressure overload-induced left ventricular hypertrophy in rats by blocking the c-Raf/ERK1/2 signaling pathway. J Card Surg 9: 81, 2014.
4. Date MO, Morita T, Yamashita N, Nishida K, Yamaguchi O, Higuchi Y, Hirotani S, Matsumura Y, Hori M, Tada M, Otsu K. The antioxidant N-2-mercaptopropionyl glycine attenuates left ventricular hypertrophy in in vivo murine pressure-overload model. J Am Coll Cardiol 39: 907–912, 2002.
5. Dhalla AK, Hill MF, Singal PK. Role of oxidative stress in transition of hypertrophy to heart failure. J Am Coll Cardiol 28: 506–514, 1996.
6. Dolinay T, Choi AMK, Ryter SW. Heme oxygenase-1/CO as protective mediators in cigarette smoke-induced lung cell injury and chronic obstructive pulmonary disease. Curr Pharm Biotechnol 13: 769–776, 2012.
7. Goldsmith CS, Bell-Pedersen D. Diverse roles for MAPK signaling in circadian clocks. Adv Genet 84: 1–39, 2013.
8. Hagiya Y, Adachi T, Ogura S, An R, Tamura A, Nakagawa H, Okura I, Mochizuki T, Ishikawa T. Nrf2-dependent induction of human ABC transporter ABCG2 and heme oxygenase-1 in HepG2 cells by photoactivation of porphyrins: biochemical implications for cancer cell response to photodynamic therapy. J Exp Ther Oncol 7: 153–167, 2008.
9. Hou J, Cai S, Kitajima Y, Fujino M, Ito H, Takahashi K, Abe F, Tanaka T, Ding Q, Li XK. 5-Aminolevulinic acid combined with ferrous iron induces carbon monoxide generation in mouse kidneys and protects from renal ischemia-reperfusion injury. Am J Physiol Renal Physiol 305: F1149–F1157, 2013.
10. Hu CM, Chen YH, Chiang MT, Chau LY. Heme oxygenase-1 inhibits angiotensin II-induced cardiac hypertrophy in vitro and in vivo. Circulation 110: 309–316, 2004.
11. Hunter GA, Ferreira GC. 5-Aminolevulinate synthase: catalysis of the first step of heme biosynthesis. Cell Mol Biol 55: 102–110, 2009.
12. Ibrahim M, Wang X, Puyo CA, Montecalvo A, Huang HJ, Hachem RR, Andreetti C, Menna C, Chen R, Krupnick AS, Kreisel D, Rendina EA, Gelman AE. Human recombinant apyrase therapy protects against canine pulmonary ischemia-reperfusion injury. J Heart Lung Transplant 34: 247–253, 2014.
13. Ishizuka M, Abe F, Sano Y, Takahashi K, Inoue K, Nakajima M, Kohda T, Komatsu N, Ogura S, Tanaka T. Novel development of 5-aminolevulinic acid (ALA) in cancer diagnoses and therapy. Int Immunopharmacol 11: 358–365, 2011.
14. Jiang G, Hu Y, Liu L, Cai J, Peng C, Li Q. Gastrodin protects against MPP_-induced oxidative stress by up regulates heme oxygenase-1 expression through p38 MAPK/Nrf2 pathway in human dopaminergic cells. Neurochem Int 75: 79–88, 2014.
15. Joshi S, Platanias LC. Mnk kinase pathway: Cellular functions and biological outcomes. World J Biol Chem 5: 321–333, 2014.
16. Knebel B, Lehr S, Hartwig S, Haas J, Kaber G, Dicken HD, Susanto F, Bohne L, Jacob S, Nitzgen U, Passlack W, Muller-Wieland D, Kotzka J. Phosphorylation of sterol regulatory element-binding protein (SREBP)-1c by p38 kinases, ERK and JNK influences lipid metabolism and the secretome of human liver cell line HepG2. Arch Physiol Biochem 120: 216–227, 2014.
17. Lee DS, Kim KS, Ko W, Li B, Jeong GS, Jang JH, Oh H, Kim YC. The cytoprotective effect of sulfuretin against tert-butyl hydroperoxide-induced hepatotoxicity through Nrf2/ARE and JNK/ERK MAPK-mediated heme oxygenase-1 expression. Int J Mol Sci 15: 8863–8877, 2014.
18. Lee JW, Bae CJ, Choi YJ, Kim SI, Kwon YS, Lee HJ, Kim SS, Chun W. 3,4,5-Trihydroxycinnamic acid inhibits lipopolysaccharide (LPS)-induced inflammation by Nrf2 activation in vitro and improves survival of mice in LPS-induced endotoxemia model in vivo. Mol Cell Biochem 390: 143–153, 2014.
19. McCommis KS, Douglas DL, Krenz M, Baines CP. Cardiac-specific hexokinase 2 overexpression attenuates hypertrophy by increasing pentose phosphate pathway flux. J Am Heart Assoc 2: e000355, 2013.
20. Melo LG, Agrawal R, Zhang L, Rezvani M, Mangi AA, Ehsan A, Griese DP, Dell’Acqua G, Mann MJ, Oyama J, Yet SF, Layne MD, Perrella MA, Dzau VJ. Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery of heme oxygenase gene. Circulation 105: 602–607, 2002.
21. Ndisang JF, Jadhav A. Heme arginate therapy enhanced adiponectin and atrial natriuretic peptide, but abated endothelin-1 with attenuation of kidney histopathological lesions in mineralocorticoid-induced hypertension. J Pharmacol Exp Ther 334: 87–98, 2010.
22. Nishio Y, Fujino M, Zhao M, Ishii T, Ishizuka M, Ito H, Takahashi K, Abe F, Nakajima M, Tanaka T, Taketani S, Nagahara Y, Li XK. 5-Aminolevulinic acid combined with ferrous iron enhances the expression of heme oxygenase-1. Int Immunopharmacol 19: 300–307, 2014.
23. Prasad V, Lorenz JN, Miller ML, Vairamani K, Nieman ML, Wang Y, Shull GE. Loss of NHE1 activity leads to reduced oxidative stress in heart and mitigates high-fat diet-induced myocardial stress. J Mol Cell Cardiol 65: 33–42, 2013.
24. Prozialeck WC. Toxicology and applied pharmacology. Foreword. Toxicol Appl Pharmacol 238: 191, 2009.
25. Reinartz M, Raupach A, Kaisers W, Godecke A. AKT1 and AKT2 induce distinct phosphorylation patterns in HL-1 cardiac myocytes. J Proteome Res 13: 4232–4245, 2014.
26. Rosa CM, Xavier NP, Henrique Campos D, Fernandes AA, Cezar MD, Martinez PF, Cicogna AC, Gimenes C, Gimenes R, Okoshi MP, Okoshi K. Diabetes mellitus activates fetal gene program and intensifies cardiac remodeling and oxidative stress in aged spontaneously hypertensive rats. Cardiovasc Diabetol 12: 152, 2013.
27. Shahidullah M, Mandal A, Delamere NA. TRPV4 in porcine lens epithelium regulates hemichannel-mediated ATP release and Na-K-ATPase activity. Am J Physiol Cell Physiol 302: C1751–C1761, 2012.
28. Shelton P, Jaiswal AK. The transcription factor NF-E2-related factor 2 (Nrf2): a protooncogene? FASEB J 27: 414–423, 2013.
29. Song BW, Vinters HV, Wu D, Pardridge WM. Enhanced neuroprotective effects of basic fibroblast growth factor in regional brain ischemia after conjugation to a blood-brain barrier delivery vector. J Pharmacol Exp Ther 301: 605–610, 2002.
30. Sykiotis GP, Habeos IG, Samuelson AV, Bohmann D. The role of the antioxidant and longevity-promoting Nrf2 pathway in metabolic regulation. Curr Opin Clin Nutr Metab Care 14: 41–48, 2011.
31. Takemoto M, Node K, Nakagami H, Liao Y, Grimm M, Takemoto Y, Kitakaze M, Liao JK. Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy. J Clin Invest 108: 1429–1437, 2001.
32. Taketani S. Aquisition, mobilization and utilization of cellular iron and heme: endless findings and growing evidence of tight regulation. Tohoku J Exp Med 205: 297–318, 2005.
33. Takimoto E, Kass DA. Role of oxidative stress in cardiac hypertrophy and remodeling. Hypertension 49: 241–248, 2007.
34. Tonon J, Guarnier FA, Brunnquell CR, Bernardes SS, Cecchini AL, Cecchini R. Oxidative status and chymotrypsin-like activity in right and left ventricle hypertrophy in an experimental model of emphysema. Pathophysiology 20: 249–256, 2013.
35. Tsiftsoglou AS, Tsamadou AI, Papadopoulou LC. Heme as key regulator of major mammalian cellular functions: Molecular, cellular, and pharmacological aspects. Pharmacol Ther 111: 327–345, 2006.
36. Yamawaki H, Haendeler J, Berk BC. Thioredoxin: a key regulator of cardiovascular homeostasis. Circ Res 93: 1029–1033, 2003.
37. Yui N, Lu HA, Chen Y, Nomura N, Bouley R, Brown D. Basolateral targeting and microtubule-dependent transcytosis of the aquaporin-2 water channel. Am J Physiol Cell Physiol 304: C38–C48, 2013.